For: | Wang L, Liu HL, Li Y, Yuan P. Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models. World J Gastroenterol 2011; 17(11): 1434-1441 [PMID: 21472101 DOI: 10.3748/wjg.v17.i11.1434] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i11/1434.htm |
Number | Citing Articles |
1 |
Wen-Jun Gu, Hai-Lin Liu. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Anti-Cancer Drugs 2013; 24(6): 566 doi: 10.1097/CAD.0b013e3283608bc5
|
2 |
Wenjun Gu, Wei Liu, Xizhong Shen, Yuan Shi, Lei Wang, Hailin Liu. Emergence of heterogeneous nuclear ribonucleoprotein A2/B1 vs loss of E-cadherin: their reciprocal immunoexpression profiles in human pancreatic cancer. Annals of Diagnostic Pathology 2013; 17(1): 14 doi: 10.1016/j.anndiagpath.2012.04.004
|
3 |
Xiaohong Li, Ying Xiao, Shaoqing Fan, Mingbing Xiao, Xiaotong Wang, Xudong Chen, Chunsun Li, Guijuan Zong, Guoxiong Zhou, Chunhua Wan. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis. Experimental and Molecular Pathology 2016; 101(2): 176 doi: 10.1016/j.yexmp.2016.08.001
|
4 |
Xiucong Pei, Jianhui Zhu, Rui Yang, Zhijing Tan, Mingrui An, Jiaqi Shi, David M. Lubman, Pankaj K Singh. CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias. PLOS ONE 2016; 11(6): e0158021 doi: 10.1371/journal.pone.0158021
|
5 |
Betty C. Villafuerte, Michelle T. Barati, Madhavi J. Rane, Susan Isaacs, Ming Li, Daniel W. Wilkey, Michael L. Merchant. Over-expression of insulin-response element binding protein-1 (IRE-BP1) in mouse pancreatic islets increases expression of RACK1 and TCTP: Beta cell markers of high glucose sensitivity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2017; 1865(2): 186 doi: 10.1016/j.bbapap.2016.10.015
|
6 |
Jun-Chao Guo, Jian Li, Ying-Chi Yang, Li Zhou, Tai-Ping Zhang, Yu-Pei Zhao, William B. Coleman. Oligonucleotide Microarray Identifies Genes Differentially Expressed during Tumorigenesis of DMBA-Induced Pancreatic Cancer in Rats. PLoS ONE 2013; 8(12): e82910 doi: 10.1371/journal.pone.0082910
|
7 |
Asaf Shilo, Vered Ben Hur, Polina Denichenko, Ilan Stein, Eli Pikarsky, Jens Rauch, Walter Kolch, Lars Zender, Rotem Karni. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. RNA 2014; 20(4): 505 doi: 10.1261/rna.042259.113
|
8 |
Anthony KC Chan, Jason IE Bruce, Ajith K Siriwardena. Glucose metabolic phenotype of pancreatic cancer. World Journal of Gastroenterology 2016; 22(12): 3471-3485 doi: 10.3748/wjg.v22.i12.3471
|
9 |
Hang Yin, Lei Wang, Hai-Lin Liu. ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/3842198
|
10 |
Mohamed J. Saadh, Hala Baher, Yuanji Li, Mvnl chaitanya, José Luis Arias-Gonzáles, Omer Qutaiba B. Allela, Mohammed H. Mahdi, Juan Carlos Cotrina-Aliaga, Natrayan Lakshmaiya, Salam Ahjel, Ali H. Amin, Gregorio Gilmer Rosales Rojas, Fuad Ameen, Muhammad Ahsan, Reza Akhavan-Sigari. The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery. Environmental Research 2023; 233: 116490 doi: 10.1016/j.envres.2023.116490
|
11 |
Mumtaz Kasim, Edgar Benko, Aline Winkelmann, Ralf Mrowka, Jonas J. Staudacher, Pontus B. Persson, Holger Scholz, Jochen C. Meier, Michael Fähling. Shutdown of Achaete-scute Homolog-1 Expression by Heterogeneous Nuclear Ribonucleoprotein (hnRNP)-A2/B1 in Hypoxia. Journal of Biological Chemistry 2014; 289(39): 26973 doi: 10.1074/jbc.M114.579391
|
12 |
Kamlesh K. Bhopale, Samir M. Amer, Lata Kaphalia, Kizhake V. Soman, John E. Wiktorowicz, Ghulam A. Shakeel Ansari, Bhupendra S. Kaphalia. Proteins Differentially Expressed in the Pancreas of Hepatic Alcohol Dehydrogenase–Deficient Deer Mice Fed Ethanol For 3 Months. Pancreas 2017; 46(6): 806 doi: 10.1097/MPA.0000000000000835
|
13 |
Sepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Masoud Delfi, Haroon Khan, Milad Ashrafizadeh, Gautam Sethi, Alan Prem Kumar. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy. Cells 2021; 10(12): 3348 doi: 10.3390/cells10123348
|
14 |
Yu Liu, Song‐Lin Shi. The roles of hnRNP A2/B1 in RNA biology and disease. WIREs RNA 2021; 12(2) doi: 10.1002/wrna.1612
|
15 |
Wei Zhang, Tingting Jiang, Keping Xie. Epigenetic reprogramming in pancreatic premalignancy and clinical implications. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1024151
|
16 |
Lei Wang, Hang Yin, Rongrong Bi, Guo Gao, Kaicheng Li, Hai‐Lin Liu. ENO1‐targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging. Journal of Cellular and Molecular Medicine 2020; 24(10): 5751 doi: 10.1111/jcmm.15237
|
17 |
Shengtao Zhou, Rui Liu, Kefei Yuan, Tao Yi, Xia Zhao, Canhua Huang, Yuquan Wei. Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis. Mass Spectrometry Reviews 2013; 32(4): 267 doi: 10.1002/mas.21362
|
18 |
Xin Wu, Xin Zhang, Peng Liu, Yao Wang. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6. Pancreatology 2023; 23(6): 630 doi: 10.1016/j.pan.2023.06.011
|
19 |
Ria Uhlig, Nina Bröker, Sören Weidemann, Natalia Gorbokon, Anne Menz, Franziska Büscheck, Andreas M. Luebke, Devita Putri, Martina Kluth, Claudia Hube-Magg, Andrea Hinsch, Maximilian Lennartz, Viktor Reiswich, Doris Höflmayer, Christoph Fraune, Katharina Möller, Christian Bernreuther, Patrick Lebok, Guido Sauter, Sarah Minner, Stefan Steurer, Eike Burandt, Rainer Krech, David Dum, Andreas Marx, Ronald Simon, Till Krech, Till S. Clauditz, Frank Jacobsen, Shuai Ren. CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas. PLOS ONE 2023; 18(6): e0287528 doi: 10.1371/journal.pone.0287528
|
20 |
Ya Li, Wen-Jun Gu, Hai-Lin Liu. Induction of Pancreatic Cancer Cell Apoptosis and Enhancement of Gemcitabine Sensitivity by RAP80 siRNA. Digestive Diseases and Sciences 2012; 57(8): 2072 doi: 10.1007/s10620-012-2132-5
|
21 |
Olena Masui, Nicole M.A. White, Leroi V. DeSouza, Olga Krakovska, Ajay Matta, Shereen Metias, Bishoy Khalil, Alexander D. Romaschin, R. John Honey, Robert Stewart, Kenneth Pace, Georg A. Bjarnason, K.W. Michael Siu, George M. Yousef. Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance. Molecular & Cellular Proteomics 2013; 12(1): 132 doi: 10.1074/mcp.M112.020701
|
22 |
Anjali Aggarwal, Vinit Sharma, Justin Jacob, Ankita Semwal, Daisy Sahni. Molecular Biomarkers for Cancer Diagnosis and Therapy. 2024; : 319 doi: 10.1007/978-981-99-3746-2_16
|
23 |
Julie Lafontaine, Francis Rodier, Véronique Ouellet, Anne-Marie Mes-Masson, Mikhail V. Blagosklonny. Necdin, a p53-Target Gene, Is an Inhibitor of p53-Mediated Growth Arrest. PLoS ONE 2012; 7(2): e31916 doi: 10.1371/journal.pone.0031916
|